Evidence for Selective Benefit of Sequential Treatment with Azanucleosides in Patients with Myelodysplastic Syndromes (MDS)
Authors:
Open Access
- 16 November 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (21) , 4937